Coagulation abnormalities in stress and depression - From evolution to gene regulation;Veränderungen der blutgerinnung bei stress und depression - Von der evolution zur genregulation

Therapeutische Umschau

Volumn 60, Issue 10, 2003, Pages 682-688

  Von Känel, Roland ^a,b  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; SEROTONIN UPTAKE INHIBITOR;

ADRENERGIC SYSTEM; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; FIBRINOLYSIS; GENE CONTROL; HUMAN; HYPERCOAGULABILITY; MENTAL STRESS; MOLECULAR BIOLOGY; MOLECULAR EVOLUTION; PSYCHOTHERAPY; REVIEW; THROMBOCYTE; ARTICLE; CORONARY RISK; DEPRESSION; EVOLUTION; PATHOGENESIS; STRESS; THROMBOCYTE FUNCTION;

ANIMALS; AROUSAL; BLOOD COAGULATION; CORONARY THROMBOSIS; DEPRESSIVE DISORDER; EVOLUTION; FIBRINOLYSIS; GENE EXPRESSION REGULATION; HUMANS; STRESS, PSYCHOLOGICAL; SYMPATHETIC NERVOUS SYSTEM; THROMBOPHILIA;

EID: 17644441542     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.60.11.682     Document Type: Review

References (57)

1. Gaffney PJ, Edgell TA, Whitton CM. The haemostatic balance - Astrup revisited. Haemostasis 1999; 29: 58-71.
2. von Kanel R, Mills PJ, Fainman C, Dimsdale JE. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom Med 2001; 63: 531-44.
3. Folsom AR. Hemostatic risk factors for atherothrombotic disease: an epidemiologic view. Thromb Haemost 2001; 86: 366-73.
4. Koenig W. Haemostatic risk factors for cardiovascular diseases. Eur Heart J 1998; 19 Suppl C: C39-43.
5. Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 2003; 89: 601-9.
6. Kohler HP, Grant PJ. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 2000; 342: 1792-801.
7. Danesh J, Whincup P, Walker M et al. Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation 2001; 103: 2323-7.
8. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20: 1262-75.
9. Falk E, Fernandez-Ortiz A. Role of thrombosis in atherosclerosis and its complications. Am J Cardiol 1995; 75: 3B-11B.
10. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999; 99: 2192-217.
11. Cannon W.B., Mendenhall W.L. Factors affecting the coagulation time of blood. IV. The hastening of coagulation in pain and emotional excitement. Am J Physiol 1914; 34: 251-61.
12. von Kanel R, Dimsdale JE, Adler KA, Patterson TL, Mills PJ, Grant I. Fibrin turnover (plasma D-dimer) is higher in Alzheimer caregivers than in non-caregiving controls. Psychosom Med 2003; 65: A23.
13. von Kanel R. Platelet hyperactivity in major depression and the beneficial effect of antidepressant drug treatment: How strong is the evidence? (submitted)
14. von Kanel R, Dimsdale JE, Patterson TL, Grant I. Acute procoagulant stress response as a dynamic measure of allostatic load in Alzheimer caregivers. Ann Behav Med; 2003; 26: 42-8.
15. Steptoe A, Kunz-Ebrecht S, Owen N et al. Influence of socioeconomic status and job control on plasma fibrinogen responses to acute mental stress. Psychosom Med 2003; 65: 137-44.
16. von Kanel R, Dimsdale JE, Adler KA, Patterson TL, Grant I. Independent association between depressed mood severity and stress procoagulant activity and recovery in the elderly. Psychosom Med 2003; 65: A65.
17. Vosburgh CH, Richards AN. An experimental study of the sugar content and extra vascular coagulation of the blood after administration of adrenalin. Am J Physiol 1903; 9: 35-51.
18. von den Velden R. Zur kreislaufanaleptischen und telehä mostyptischen Wirkung des Nebennierenextraktes. Münch Med Wschr 1911; 58: 184-8.
19. Friedman M. Rosenman RH. Association of specific overt behavior pattern with blood and cardiovascular findings. JAMA 1959; 169: 1286-96.
20. Schneider RA, Zangari VM. Variations in clotting time, relative viscosity, and other physiochemical properties of the blood accompanying physical and emotional stress in the normal and hypertensive subject. Psychosom Med 1951; 13: 289-303.
21. Latner AL. Anxiety as a cause of fibrinolysis. Lancet 1947; 1: 194-5.
22. Truelove SC. Fibrinolysis and the eosinophil count. Clin Sci 1951; 10: 229-40.
23. Lotti T, Benci M, Sarti MG et al. Psychogenic purpura with abnormally increased tPA dependent cutaneous fibrinolytic activity. Int J Dermatol 1993; 32: 521-3.
24. von Kanel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000; 65: 357-69.
25. Mannucci PM, Ruggeri ZM, Gagnatelli G. Nervous regulation of factor-VIII levels in man. Br J Haematol 1971; 20: 539-49.
26. Gunn CG, Hampton JW. CNS influence on plasma levels of factor 8 activity. Am J Physiol 1967; 212: 124-30.
27. Camacho A, Dimsdale JE. Platelets and psychiatry: lessons learned from old and new studies. Psychosom Med 2000; 62: 326-36.
28. von Kanel R, Mills PJ, Ziegler MG, Dimsdale JE. Effect of beta2-adrenergic receptor functioning and increased norepinephrine on the hypercoagulable state with mental stress. Am Heart J 2002; 144: 68-72.
29. Tomoda F, Takata M, Kagitani S et al. Different platelet aggregability during mental stress in two stages of essential hypertension. Am J Hypertens 1999; 12: 1063-70.
30. Grignani G, Pacchiarini L, Zucchella M et al. Effect of mental stress on platelet function in normal subjects and in patients with coronary artery disease. Haemostasis 1992; 22: 138-46.
31. Palermo A, Bertalero P, Pizza N, Amelotti R, Libretti A. Decreased fibrinolytic response to adrenergic stimulation in hypertensive patients. J Hypertens Suppl 1989; 7: S162-3.
32. Canevari A, Tacconi F, Zucchella M, Pacchiarini L, Soffiantino F, Grignani G. Antithrombin III biological activity and emotional stress in patients with coronary artery disease. Haematologica 1992; 77: 180-2.
33. von Kanel R, Dimsdale JE, Ziegler MG et al. Effect of acute psychological stress on the hypercoagulable state in subjects (spousal caregivers of patients with Alzheimer's disease) with coronary or cerebrovascular disease and/or systemic hypertension. Am J Cardiol 2001; 87: 1405-8.
34. Lande K, Kjeldsen SE, Os I et al. Increased platelet and vascular smooth muscle reactivity to low-dose adrenaline infusion in mild essential hypertension. J Hypertens 1988; 6: 219-25.
35. von Kanel R, Dimsdale JE, Adler KA, Dillon E, Perez CJ, Mills PJ. Effects of nonspecific beta-adrenergic stimulation and blockade on blood coagulation in hypertension. J Appl Physiol 2003; 94: 1455-9.
36. Dimsdale JE, Ziegler MG. What do plasma and urinary measures of catecholamines tell us about human response to stressors? Circulation 1991; 83(4 Suppl): 1136-42.
37. von Kanel R, Dimsdale JE. Fibrin D-dimer: a marker of psychosocial distress and its implications for research in stress-related coronary artery disease. Clin Cardiol 2003; 26: 164-8.
38. von Kanel R, Dimsdale JE, Patterson TL, Grant I. Association of negative life event stress with coagulation activity in elderly Alzheimer caregivers. Psychosom Med 2003; 65: 145-50.
39. Ishizaki M, Tsuritani I, Noborisaka Y, Yamada Y, Tabata M, Nakagawa H. Relationship between job stress and plasma fibrinolytic activity in male Japanese workers. Int Arch Occup Environ Health 1996; 68: 315-20.
40. Vrijkotte TG, van Doornen LJ, de Geus EJ. Work stress and metabolic and hemostatic risk factors. Psychosom Med 1999; 61: 796-805.
41. Appels A, Mulder P. Excess fatigue as a precursor of myocardial infarction. Eur Heart J 1988; 9: 758-64.
42. Kop WJ, Appels AP, Mendes de Leon CF, de Swart HB, Bar FW. Vital exhaustion predicts new cardiac events after successful coronary angioplasty. Psychosom Med 1994; 56: 281-7.
43. van Diest R, Hamulyak K, Kop WJ, van Zandvoort C, Appels A. Diurnal variations in coagulation and fibrinolysis in vital exhaustion. Psychosom Med 2002; 64: 787-92.
44. von Kanel R, Maly FE, Frey K, Fischer JE. Contribution of the plasminogen activator inhibitor 1 4G/5G polymorphism to impaired fibrinolysis in vital exhaustion. Ital Heart J 2003; in press.
45. Yamamoto K, Takeshita K, Shimokawa T et al. Plasminogen activator inhibitor-1 is a major stress-regulated gene: implications for stress induced thrombosis in aged individuals. Proc Natl Acad Sci U S A. 2002; 99: 890-5.
46. Venugopal B, Sharon R, Abramovitz R, Khasin A, Miskin R. Plasminogen activator inhibitor-1 in cardiovascular cells: rapid induction after injecting mice with kainate or adrenergic agents. Cardiovasc Res 2001; 49: 476-83.
47. von Kanel R, Kudielka BM, Abd-el-Razik A, Frey K, Fischer JE. Effect of overnight neuroendocrine activity on morning hemostasis in working men (submitted).
48. Musselman DL, Tomer A, Manatunga AK et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996; 153: 1313-7.
49. Musselman DL, Marzec UM, Manatunga A et al. Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch Gen Psychiatry 2000; 57: 875-82.
50. Markovitz JH, Shuster JL, Chitwood WS, May RS, Tolbert LC. Platelet activation in depression and effects of sertraline treatment: An open-label study. Am J Psychiatry 2000; 157: 1006-8.
51. Walsh MT, Dinan TG, Condren RM, Ryan M, Kenny D. Depression is associated with an increase in the expression of the platelet adhesion receptor glycoprotein Ib. Life Sci 2002; 70: 3155-65.
52. Laghrissi-Thode F, Wagner WR, Pollock BG, Johnson PC, Finkel MS. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry 1997; 42: 290-5.
53. Shimbo D, Child J, Davidson K et al. Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes. Am J Cardiol 2002; 89: 331-3.
54. Layton D, Clark DW, Pearce GL, Shakir SA. Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England. Eur J Clin Pharmacol 2001; 57: 167-76.
55. Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population based cohort study. Arch Intern Med 2003; 163: 59-64.
56. Serebruany VL, O'Connor CM, Gurbel PA. Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease. Am J Cardiol 2001; 87: 1398-400.
57. Sheps DS, Freedland KE, Golden RN, McMahon RP. ENRICHD and SADHART: implications for future biobehavioral intervention efforts. Psychosom Med 2003; 65: 1-2.